# Arcosa, Inc.: financial statements, quarterly

ACA · NYSE · CIK 1739445 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aca.md) · [Financials](/companies/aca/financials.md) · [Filings](/companies/aca/filings.md) · [Insiders](/companies/aca/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aca/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [592](/filings/0001739445-24-000150.md) | [582 d](/filings/0001739445-26-000029.md) | [599](/filings/0001739445-25-000067.md) | [665](/filings/0001739445-25-000115.md) | [640](/filings/0001739445-25-000135.md) | [666 d](/filings/0001739445-26-000029.md) | [548](/filings/0001739445-26-000067.md) | [648](/filings/0001739445-26-000126.md) | [798](/filings/0001739445-25-000135.md) | [717 d](/filings/0001739445-26-000029.md) | [572](/filings/0001739445-26-000067.md) | [659](/filings/0001739445-26-000126.md) |
| Cost of revenue | $m | [485](/filings/0001739445-24-000150.md) | [475 d](/filings/0001739445-26-000029.md) | [487](/filings/0001739445-25-000067.md) | [527](/filings/0001739445-25-000115.md) | [504](/filings/0001739445-25-000135.md) | [537 d](/filings/0001739445-26-000029.md) | [440](/filings/0001739445-26-000067.md) | [497](/filings/0001739445-26-000126.md) | [606](/filings/0001739445-25-000135.md) | [553 d](/filings/0001739445-26-000029.md) | [451](/filings/0001739445-26-000067.md) | [503](/filings/0001739445-26-000126.md) |
| Gross profit | $m | not reported | not reported | not reported | [138](/filings/0001739445-25-000115.md) | [137](/filings/0001739445-25-000135.md) | [129 d](/filings/0001739445-26-000029.md) | [108](/filings/0001739445-26-000067.md) | [150](/filings/0001739445-26-000126.md) | [192](/filings/0001739445-25-000135.md) | [164 d](/filings/0001739445-26-000029.md) | [121](/filings/0001739445-26-000067.md) | [156](/filings/0001739445-26-000126.md) |
| Selling, general and administrative | $m | [61.3](/filings/0001739445-24-000150.md) | [66.6 d](/filings/0001739445-26-000029.md) | [69.1](/filings/0001739445-25-000067.md) | [79.5](/filings/0001739445-25-000115.md) | [82.4](/filings/0001739445-25-000135.md) | [89.0 d](/filings/0001739445-26-000029.md) | [71.0](/filings/0001739445-26-000067.md) | [70.0](/filings/0001739445-26-000126.md) | [82.2](/filings/0001739445-25-000135.md) | [78.2 d](/filings/0001739445-26-000029.md) | [75.8](/filings/0001739445-26-000067.md) | [89.1](/filings/0001739445-26-000126.md) |
| Operating income | $m | [48.4](/filings/0001739445-24-000150.md) | [42.8 d](/filings/0001739445-26-000029.md) | [53.4](/filings/0001739445-25-000067.md) | [67.2](/filings/0001739445-25-000115.md) | [33.8](/filings/0001739445-25-000135.md) | [43.2 d](/filings/0001739445-26-000029.md) | [41.0](/filings/0001739445-26-000067.md) | [82.0](/filings/0001739445-26-000126.md) | [112](/filings/0001739445-25-000135.md) | [79.0 d](/filings/0001739445-26-000029.md) | [47.1](/filings/0001739445-26-000067.md) | [84.3](/filings/0001739445-26-000126.md) |
| Interest expense | $m | [6.7](/filings/0001739445-24-000150.md) | [7.2 d](/filings/0001739445-24-000012.md) | [8.3](/filings/0001739445-25-000067.md) | [11.4](/filings/0001739445-25-000115.md) | [15.8](/filings/0001739445-25-000135.md) | [35.4 d](/filings/0001739445-26-000029.md) | [28.3](/filings/0001739445-26-000067.md) | [28.5](/filings/0001739445-26-000126.md) | [27.1](/filings/0001739445-25-000135.md) | [24.9 d](/filings/0001739445-26-000029.md) | [24.0](/filings/0001739445-26-000067.md) | [23.1](/filings/0001739445-26-000126.md) |
| Income tax | $m | [7.5](/filings/0001739445-24-000150.md) | [9.4 d](/filings/0001739445-26-000029.md) | [8.1](/filings/0001739445-25-000067.md) | [7.6](/filings/0001739445-25-000115.md) | [2.5](/filings/0001739445-25-000135.md) | [18.1 d](/filings/0001739445-26-000029.md) | [2.8](/filings/0001739445-26-000067.md) | [6.5](/filings/0001739445-26-000126.md) | [14.1](/filings/0001739445-25-000135.md) | [3.1 d](/filings/0001739445-26-000029.md) | [1.3](/filings/0001739445-26-000067.md) | [11.4](/filings/0001739445-26-000126.md) |
| Net income | $m | [35.5](/filings/0001739445-24-000150.md) | [27.1 d](/filings/0001739445-26-000029.md) | [39.2](/filings/0001739445-25-000067.md) | [45.6](/filings/0001739445-25-000115.md) | [16.6](/filings/0001739445-25-000135.md) | [(7.7) d](/filings/0001739445-26-000029.md) | [23.6](/filings/0001739445-26-000067.md) | [59.7](/filings/0001739445-26-000126.md) | [73.0](/filings/0001739445-25-000135.md) | [52.1 d](/filings/0001739445-26-000029.md) | [37.8](/filings/0001739445-26-000067.md) | [329](/filings/0001739445-26-000126.md) |
| Diluted EPS | $ per share | [0.72](/filings/0001739445-24-000150.md) | not reported | [0.80](/filings/0001739445-25-000067.md) | [0.93](/filings/0001739445-25-000115.md) | [0.34](/filings/0001739445-25-000135.md) | not reported | [0.48](/filings/0001739445-26-000067.md) | [1.22](/filings/0001739445-26-000126.md) | [1.48](/filings/0001739445-25-000135.md) | not reported | [0.77](/filings/0001739445-26-000067.md) | [6.67](/filings/0001739445-26-000126.md) |
| Basic EPS | $ per share | [0.73](/filings/0001739445-24-000150.md) | not reported | [0.81](/filings/0001739445-25-000067.md) | [0.93](/filings/0001739445-25-000115.md) | [0.34](/filings/0001739445-25-000135.md) | not reported | [0.48](/filings/0001739445-26-000067.md) | [1.22](/filings/0001739445-26-000126.md) | [1.49](/filings/0001739445-25-000135.md) | not reported | [0.77](/filings/0001739445-26-000067.md) | [6.68](/filings/0001739445-26-000126.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [155](/filings/0001739445-23-000147.md) | [105](/filings/0001739445-25-000026.md) | [177](/filings/0001739445-24-000067.md) | [104](/filings/0001739445-24-000114.md) | [757](/filings/0001739445-24-000150.md) | [187](/filings/0001739445-26-000029.md) | [168](/filings/0001739445-25-000067.md) | [190](/filings/0001739445-25-000115.md) | [220](/filings/0001739445-25-000135.md) | [215](/filings/0001739445-26-000126.md) | [153](/filings/0001739445-26-000067.md) | [432](/filings/0001739445-26-000126.md) |
| Current assets | $m | [952](/filings/0001739445-23-000147.md) | [912](/filings/0001739445-25-000026.md) | [994](/filings/0001739445-24-000067.md) | [991](/filings/0001739445-24-000114.md) | [1,560](/filings/0001739445-24-000150.md) | [954](/filings/0001739445-26-000029.md) | [1,011](/filings/0001739445-25-000067.md) | [1,117](/filings/0001739445-25-000115.md) | [1,172](/filings/0001739445-25-000135.md) | [1,107](/filings/0001739445-26-000126.md) | [1,133](/filings/0001739445-26-000067.md) | [1,411](/filings/0001739445-26-000126.md) |
| Total assets | $m | [3,490](/filings/0001739445-23-000147.md) | [3,578](/filings/0001739445-26-000029.md) | [3,668](/filings/0001739445-25-000067.md) | [3,808](/filings/0001739445-25-000115.md) | [4,357](/filings/0001739445-25-000135.md) | [4,916](/filings/0001739445-26-000029.md) | [4,934](/filings/0001739445-25-000067.md) | [5,012](/filings/0001739445-25-000115.md) | [5,053](/filings/0001739445-25-000135.md) | [4,985](/filings/0001739445-26-000126.md) | [5,002](/filings/0001739445-26-000067.md) | [5,302](/filings/0001739445-26-000126.md) |
| Current liabilities | $m | [405](/filings/0001739445-23-000147.md) | [431](/filings/0001739445-25-000026.md) | [435](/filings/0001739445-24-000067.md) | [429](/filings/0001739445-24-000114.md) | [432](/filings/0001739445-24-000150.md) | [516](/filings/0001739445-26-000029.md) | [510](/filings/0001739445-25-000067.md) | [528](/filings/0001739445-25-000115.md) | [580](/filings/0001739445-25-000135.md) | [504](/filings/0001739445-26-000126.md) | [490](/filings/0001739445-26-000067.md) | [452](/filings/0001739445-26-000126.md) |
| Total liabilities | $m | [1,174](/filings/0001739445-23-000147.md) | [1,246](/filings/0001739445-25-000026.md) | [1,294](/filings/0001739445-24-000067.md) | [1,393](/filings/0001739445-24-000114.md) | [1,923](/filings/0001739445-24-000150.md) | [2,487](/filings/0001739445-26-000029.md) | [2,479](/filings/0001739445-25-000067.md) | [2,503](/filings/0001739445-25-000115.md) | [2,468](/filings/0001739445-25-000135.md) | [2,344](/filings/0001739445-26-000126.md) | [2,350](/filings/0001739445-26-000067.md) | [2,319](/filings/0001739445-26-000126.md) |
| Shareholders' equity | $m | [2,315](/filings/0001739445-24-000150.md) | [2,332](/filings/0001739445-26-000029.md) | [2,374](/filings/0001739445-25-000115.md) | [2,415](/filings/0001739445-25-000135.md) | [2,434](/filings/0001739445-25-000135.md) | [2,428](/filings/0001739445-26-000126.md) | [2,455](/filings/0001739445-26-000126.md) | [2,508](/filings/0001739445-26-000126.md) | [2,585](/filings/0001739445-25-000135.md) | [2,641](/filings/0001739445-26-000126.md) | [2,653](/filings/0001739445-26-000126.md) | [2,983](/filings/0001739445-26-000126.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [43.9 d](/filings/0001739445-24-000150.md) | [62.2 d](/filings/0001739445-26-000029.md) | [80.5](/filings/0001739445-25-000067.md) | [38.3 d](/filings/0001739445-25-000115.md) | [135 d](/filings/0001739445-25-000135.md) | [248 d](/filings/0001739445-26-000029.md) | [(0.7)](/filings/0001739445-26-000067.md) | [61.2 d](/filings/0001739445-26-000126.md) | [161 d](/filings/0001739445-25-000135.md) | [120 d](/filings/0001739445-26-000029.md) | [71.9](/filings/0001739445-26-000067.md) | [(11.2) d](/filings/0001739445-26-000126.md) |
| Capital expenditure | $m | [47.9 d](/filings/0001739445-24-000150.md) | [58.7 d](/filings/0001739445-26-000029.md) | [54.4](/filings/0001739445-25-000067.md) | [47.6](/filings/0001739445-25-000115.md) | [34.4](/filings/0001739445-25-000135.md) | [53.3 d](/filings/0001739445-26-000029.md) | [33.0](/filings/0001739445-26-000067.md) | [27.8](/filings/0001739445-25-000115.md) | [39.6](/filings/0001739445-25-000135.md) | [64.2 d](/filings/0001739445-26-000029.md) | [43.5](/filings/0001739445-26-000067.md) | [58.8 d](/filings/0001739445-26-000126.md) |
| Dividends paid | $m | [2.5](/filings/0001739445-24-000150.md) | [2.5 d](/filings/0001739445-26-000029.md) | [2.4](/filings/0001739445-25-000067.md) | [2.5](/filings/0001739445-25-000115.md) | [2.4](/filings/0001739445-25-000135.md) | [2.4 d](/filings/0001739445-26-000029.md) | [2.5](/filings/0001739445-26-000067.md) | [2.5](/filings/0001739445-26-000126.md) | [2.5](/filings/0001739445-25-000135.md) | [2.5 d](/filings/0001739445-26-000029.md) | [2.4](/filings/0001739445-26-000067.md) | [2.5](/filings/0001739445-26-000126.md) |
| Share repurchases | $m | [0.0 d](/filings/0001739445-23-000147.md) | [13.8 d](/filings/0001739445-26-000029.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001739445-26-000067.md) | [0.0 d](/filings/0001739445-26-000126.md) | not reported | not reported | [17.5](/filings/0001739445-26-000067.md) | [0.0 d](/filings/0001739445-26-000126.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [48.5](/filings/0001739445-23-000147.md) | [48.8](/filings/0001739445-24-000067.md) | [48.7](/filings/0001739445-24-000114.md) | [48.8](/filings/0001739445-24-000150.md) | [48.9](/filings/0001739445-25-000067.md) | [48.7](/filings/0001739445-25-000115.md) | [48.8](/filings/0001739445-25-000135.md) | [49.2](/filings/0001739445-26-000067.md) | [49.0](/filings/0001739445-26-000126.md) | [49.1](/filings/0001739445-25-000135.md) | [49.2](/filings/0001739445-26-000067.md) | [49.2](/filings/0001739445-26-000126.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 49,106,809 at 2026-07-15, from the cover of the [10-Q filed 2026-08-05](/filings/0001739445-26-000126.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.